MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517056266 A) filed by Takeda Vaccines, Inc., Cambridge, U.S.A., on June 11, for 'a method for the quantitative determination of human serum albumin monomer in virus-containing pharmaceutical compositions.'
Inventor(s) include Somanadhan, Brinda.
The application for the patent was published on July 4, under issue no. 27/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to methods for the quantitative determination of human serum albumin (HSA) monomer in virus-containing, in particular flavivirus, pharmaceutical compositions. The present invention also relates to the use of the methods in the...